UnitedHealth is exposed as health insurance costs become unaffordable for employers: an industry that lives by price gouging will die by it. US employers face the largest health insurance cost hike since the Affordable Care Act began, with a 25% rise expected in 2027 after a massive drop in exchange enrollment. Employer-based health plans now look set to go the way of pensions and become extinct. x.com 

UnitedHealth's debt has to come down to a manageable $20-30B, which would also cut interest expense, and the institutions, TV contributors and big retail accounts pumping it like the next Nvidia are ignoring that. Health insurance is not going away, but the numbers matter more than the hype. x.com 

Healthcare is the clearest place money is moving, and UnitedHealth is the preferred name here. It beat earnings and raised its 2026 profit forecast. x.com 

UnitedHealth's model is a conflict of interest, since it owns both the insurer and the doctors and data, which makes it too dark to own. It has been accused of using algorithms to systematically deny care to the elderly and sick to lift profits; as both the largest US employer of doctors and an insurer, the patient loses. The assassination of its CEO showed deep hostility toward that system. A moat built on denying care is not worth owning. x.com 

US healthcare and biotech stocks are coming under distribution as the attack on healthcare returns. Per Dr Alex Kenton, the No Surprises Act has knocked millions of people off insurance rolls, hurting hospitals, and a new Justice Department investigation targets Cigna, UnitedHealth and CVS over allegedly using Claritev to fix prices. x.com 

UnitedHealth's potential earnings recovery and margin expansion offer a fundamental case for its emerging Stage 2 uptrend. EPS is expected to grow 53%, from $20.47 in 2026 to $31.31 by 2029, while revenue is projected to rise from $448B to $511B; a weekly bull flag has broken out. x.com 

Oscar Health's ACA expansion offers a huge growth opportunity if it controls medical costs. It is entering six South Carolina counties in 2027; management targets another 400-600 counties by 2029. Q2 MLR fell to 79.2% from 91.1%, SG&A to 14.2% from 18.7%, and operating income rose from a $230M loss to a $389M profit. Favorable reserve development helped, so those results may not be the new normal. If underlying economics keep improving, Oscar could look very different in a few years. x.com  x.com 

Oscar Health's guidance raise shows improving operating leverage, the key test of whether its ACA growth can become durable profit. It lifted 2026 earnings from operations guidance to $600M-$800M from $500M-$700M while leaving revenue guidance unchanged at $18.7B-$19.0B, and improved medical loss ratio guidance by 50 bps to 81.0%-82.0%. The implied operating margin rises from about 3.2% to 3.7% without more revenue. ACA risk adjustment and medical-cost trends still need watching. x.com  x.com 

UnitedHealth collects ever-rising US healthcare spending, and its stock has stopped falling. Family plan costs rose 249% in two decades toward $24,000, US spending nears $10,000 a person, and the over-65 population is set to double to two billion by 2050. After earnings fell 59% and 69% in back-to-back quarters and the stock dropped from 606 to 248, it based near 250 for a year, a Weinstein Stage 1, then reclaimed its moving average and pushed above 400. x.com  x.com  x.com  x.com 

UnitedHealth's regulatory risk looks too excessive to justify holding it at its valuation, and owning it in the first place was a mistake. x.com